Elkhorn Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,600
| Closed | -$594K | – | 50 |
|
|
2022
Q2 | $594K | Buy |
18,600
+1,650
| +10% | +$52.7K | 0.38% | 11 |
|
|
2022
Q1 | $587K | Buy |
16,950
+2,150
| +15% | +$74.5K | 0.32% | 10 |
|
|
2021
Q4 | $433K | Buy |
14,800
+100
| +0.7% | +$2.93K | 0.24% | 13 |
|
|
2021
Q3 | $375K | Buy |
14,700
+8,400
| +133% | +$214K | 0.23% | 14 |
|
|
2021
Q2 | $221K | Buy |
6,300
+5,150
| +448% | +$181K | 0.14% | 19 |
|
|
2021
Q1 | $47K | Buy |
1,150
+850
| +283% | +$34.7K | 0.03% | 30 |
|
|
2020
Q4 | $13K | Buy |
+300
| New | +$13K | 0.01% | 32 |
|